Although mutations in the BRCA1 RING domain occur frequently in tumours (83,84), there are conflicting data on the importance of the RING domain for the recruitment of the heterodimer to specific DNA lesions (85–87) and whether the E3 ligase activity of BRCA1 is involved in tumour suppression. Here, BRCA1 is linked to neoplasm.